Add to Basket
Order hotline:
+1 404 474 4654
+1 888 205 9894 (TF)

Tubulin, Beta, 3 (TUBB3) antibody

Antigen

Tubulin, Beta, 3 (TUBB3)

Synonyms TUBB3, TUBB4, MGC134115, MC1R, beta-4, tbb3, M(beta)3, M(beta)6, 3200002H15Rik, tubb3, MGC76202, TUBB1, tubB3, tubulin
Clonality Monoclonal (TU-20)
Host
Alternatives

Mouse

Reactivity
Alternatives

Various Species

Application
Alternatives Flow Cytometry (FACS), Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Radioimmunoassay (RIA), Immunocytochemistry (ICC)
7 references available
Catalog no. ABIN93911
Quantity 0.1 mg  (1 mg/ml)
Price 312.00 $   Plus shipping costs $35.00
Shipping to
Availability Ships within 3 to 5 Business days

Additional Information

Alternative name betaIII-tubulin
Immunogen Peptide (C) 441-448 coupled to maleimide-activated keyhole limpet hemocyanin viacysteine added to the N-terminus of the neuron-specific peptide.
Format Purified
Isotype IgG1  (Matching secondary antibodies)
Clone TU-20
Description The betaIII-tubulin isoform is present dominantly in cells of neuronal origin and it is one ofthe earliest markers of neuronal differentiation. It is regarded as a specific probe for the cellsof neuronal origin as well as for the tumours originating from these cells. The betaIII-tubulinis most abundant in cells of neuronal origin, but was also detected in Sertoli cells of thetestis and transiently in non-neuronal embryonic tissues.
Specificity The antibody TU-20 recognizes C-terminal peptide sequence ESESQGPK (aa 441-448) ofneuron-specific human betaIII-tubulin.

Application Details

Application Notes Western Blotting - Recommended dilution: 1-2 µg/ml, 90 min Positive control: Porcine brain lysate. Negative control: HPB-ALL human peripheral blood leukemia cell line. Sample preparation: Mix lysate with reducing Laemmli SDS-PAGE sample buffer. Application note: Reducing conditions. Immunohistochemistry (paraffin sections) - Recommended dilution: 10 µg/ml Staining technique: Standard ABC technique (DAB+)Pretreatment: 0.1% pepsin (trypsin) in 0.1 M HCl, incubation 30 min in RT, or Hightemperature citrate buffer antigen retrieval Positive tissue: neuronal tissue. Immunocytochemistry - Positive material: Neuro2a mouse neuroblastoma cell line
Concentration 1 mg/ml
Purity > 95% (by SDS-PAGE)
Purification Purified from ascites by precipitation methods.
Buffer Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
Storage Store at 2-8 o C. Do not use after expiration date stamped on vial label. For long-term storage aliquot and store at -20 o C. Avoid freeze/thaw cycles.
Restrictions For Research Use only

Publications

Publications Draberova E, Lukas Z, Ivanyi D et al.: "Expression of class III beta-tubulin in normal and neoplastic human tissues." in: Histochem Cell Biol, Vol. 109, Issue 3, pp. 231-9, 1998 (PubMed).

P?knicova, Kubatova, Sulimenko et al.: "Differential subcellular distribution of tubulin epitopes in boar spermatozoa: recognition of class III beta-tubulin epitope in sperm tail." in: Biology of reproduction, Vol. 65, Issue 3, pp. 672-9, 2001 (PubMed).

Woltjen, Michael, Mohseni et al.: "piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells." in: Nature, Vol. 458, Issue 7239, pp. 766-70, 2009 (PubMed).

Silva, Pereira, Oliveira et al.: "BDNF and extracellular matrix regulate differentiation of mice neurosphere-derived cells into a GABAergic neuronal phenotype." in: Journal of neuroscience research, Vol. 87, Issue 9, pp. 1986-96, 2009 (PubMed).

Theodorou, Dalembert, Heffelfinger et al.: "A high throughput embryonic stem cell screen identifies Oct-2 as a bifunctional regulator of neuronal differentiation." in: Genes & development, Vol. 23, Issue 5, pp. 575-88, 2009 (PubMed).

Kunova, Matulka, Eiselleova et al.: "Development of humanized culture medium with plant-derived serum replacement for human pluripotent stem cells." in: Reproductive biomedicine online, Vol. 21, Issue 5, pp. 676-86, 2010 (PubMed).

Gun?ova: "The neurodegenerative process in a neurotoxic rat model and in patients with Huntington's disease: Histopathological parallels and differences." in: Acta histochemica, 2011 (PubMed).